Natural Alternatives International Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $141.9M+24.7% YoYTTM through 31 Mar 2026
Net Income -$14.4MTTM through 31 Mar 2026
Free Cash Flow -$9MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | -2.0% |
| Operating Margin | -1,127.0% |
| Net Margin | -10.1% |
Returns
-20.6%ROE
-9.3%ROA
Balance Sheet Health
Debt / Equity0.30x
Current Ratio2.57x
Net Debt$9.5M
Cash & Equivalents$9.2M
Quality Metrics
Altman Z-Score1.50
Piotroski F-Score3 / 9
FCF Margin-6.4%
Multi-Year Trend
RevenueFY2025: $129.9M
Diluted EPS-$2.40TTMFY2025: $-2.28
Dividend
No dividend
Capital Allocation
R&D Spend$1.8M
Capex Intensity3.2%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.